About
Nuvo's INVU™ platform is a clinically validated, FDA-cleared wearable solution for remote pregnancy monitoring. Designed for mothers, clinicians, and payers, INVU enables self-administered fetal nonstress tests (NSTs) at home — eliminating the burden of repeated hospital or clinic visits, especially for high-risk pregnancies. The workflow is straightforward: a clinician prescribes INVU, the monitoring kit is shipped to the expectant mother, and she completes self-guided training via a free mobile app. The clinician then schedules remote monitoring sessions, reviews and interprets fetal and uterine data through the platform, and closes sessions with EMR-integrated documentation. Powered by AI, INVU captures uterine contraction patterns and fetal heart rate data with clinical-grade accuracy, backed by peer-reviewed research published in the American Journal of Obstetrics & Gynecology (AJOG). The platform also features the INVU Data Lake, enabling population-level maternal-fetal research and continuous AI model improvement. Nuvo specifically targets the growing issue of 'pregnancy care deserts' — geographic regions where access to in-person maternal-fetal care is limited. For payers and health systems, the platform offers a pathway to reducing maternity care costs while improving patient outcomes. For clinicians, it extends care delivery beyond the clinic. For mothers, it provides peace of mind and convenience without sacrificing clinical oversight.
Key Features
- FDA-Cleared Wearable Device: The INVU™ wearable is FDA-cleared (K210025) and clinically validated for remote fetal heart rate and uterine contraction monitoring.
- At-Home Nonstress Testing: Mothers can self-administer nonstress tests (NSTs) from home using a guided mobile app, reducing the need for repeated clinic visits.
- Remote Clinician Review & EMR Integration: Clinicians schedule, monitor, and interpret sessions remotely, then seamlessly integrate session data into existing electronic medical record (EMR) systems.
- AI-Powered Maternal-Fetal Data Lake: The INVU Data Lake aggregates real-world monitoring data to power AI model improvement and enable maternal-fetal population health research.
- Pregnancy Care Desert Outreach: Designed to extend clinical-grade monitoring to patients in underserved or geographically isolated areas with limited access to maternal-fetal specialists.
Use Cases
- Remote nonstress testing (NST) for high-risk pregnancies, allowing expectant mothers to complete monitoring sessions at home instead of traveling to a clinic.
- Extending prenatal care access to patients living in pregnancy care deserts or rural areas with limited access to maternal-fetal medicine specialists.
- Reducing maternity care costs for payers and health systems by replacing repeat in-office NST visits with efficient remote monitoring sessions.
- Enabling clinicians to manage larger patient panels by reviewing fetal monitoring data remotely without requiring in-person appointments for routine NSTs.
- Supporting maternal-fetal research through the INVU Data Lake, which aggregates real-world monitoring data to advance AI models and population health insights.
Pros
- Clinically Validated & FDA-Cleared: Backed by peer-reviewed AJOG research and FDA clearance, giving clinicians and patients confidence in the accuracy and safety of remote monitoring.
- Reduces In-Person Visit Burden: Enables high-risk pregnant patients to complete nonstress tests at home, saving time and reducing stress — especially for those with mobility or transportation challenges.
- Addresses Access Disparities: Directly targets maternal care deserts, expanding access to quality prenatal monitoring for underserved populations across the U.S.
- Seamless Clinical Workflow Integration: Session data flows directly into EMR systems, minimizing administrative burden and keeping care continuity intact for providers.
Cons
- Requires Clinician Prescription: The platform cannot be accessed directly by patients — a clinician must prescribe and manage the INVU monitoring program, limiting self-service use.
- Pricing Not Publicly Listed: Cost information is not available on the website; pricing depends on payer agreements and healthcare system contracts, making it difficult to evaluate independently.
- Limited to Supported Healthcare Systems: Availability and EMR integration may vary depending on the healthcare provider's system compatibility and institutional adoption of the platform.
Frequently Asked Questions
What is the INVU™ platform?
INVU™ is Nuvo's FDA-cleared remote fetal monitoring platform. It includes a wearable device and mobile app that allow pregnant mothers to perform nonstress tests (NSTs) at home, with clinicians reviewing and interpreting results remotely.
Is Nuvo's technology FDA-cleared?
Yes. The INVU™ device holds FDA clearance (K210025) and has been validated through peer-reviewed clinical studies published in the American Journal of Obstetrics & Gynecology.
How does a mother get started with INVU?
A clinician prescribes INVU to the expectant mother. A monitoring kit is shipped to her home, she downloads the free mobile app, registers her device, and completes self-guided training sessions before beginning remote monitoring.
Can INVU integrate with electronic medical records (EMR)?
Yes. After a clinician reviews and closes a remote monitoring session, the session data can be integrated directly into supported EMR systems, maintaining seamless clinical documentation.
Who is Nuvo designed for?
Nuvo serves three primary audiences: pregnant mothers who benefit from at-home monitoring convenience, clinicians who need to extend care beyond the clinic, and payers or health administrators seeking to improve outcomes and reduce maternity care costs.
